Literature DB >> 17628586

Flow cytometric detection of degranulation reveals phenotypic heterogeneity of degranulating CMV-specific CD8+ T lymphocytes in rhesus macaques.

Kenneth S Chan1, Amitinder Kaur.   

Abstract

Flow-cytometric conditions for detection of lysosomal-associated membrane proteins (LAMPs) on the surface of recently degranulated cells were optimized for rhesus macaques and used to investigate the functional properties of rhesus cytomegalovirus (rhCMV)-specific CD8+ T lymphocytes with regards to cytotoxicity and interferon (IFN)-gamma secretion in six asymptomatic CMV-seropositive rhesus macaques. Unlike humans, the rhesus macaque LAMP-1 protein CD107a underwent little or no endocytosis over a six to 18 h stimulation period. Following in vitro stimulation, rhCMV-specific CD8+ T lymphocytes were heterogeneous with regards to the composition of cells positive for CD107a and/or IFN-gamma, time to reach peak degranulation, and kinetics of IFN-gamma secretion relative to degranulation. Responder CD8+ T lymphocytes that underwent degranulation without IFN-gamma production (CD107a+IFN-gamma-) were predominantly composed of terminally differentiated effectors (CD28-CD45RA+). Moreover, they had significantly lower frequencies of effector memory (CD28-CD45RA-) cells compared to the IFN-gamma-secreting cells that did or did not undergo degranulation (CD107a+IFN-gamma+ or CD107a-IFN-gamma+). The perforin content of effector CD8+ T lymphocytes was significantly greater than that of effector memory CD8+ T lymphocytes in rhesus macaques, suggesting that they were more cytolytic. Our findings suggest that the composition of rhCMV-specific CD8+ T lymphocytes with regards to CD107a+IFN-gamma- responders may be an important determinant of their ability to control CMV replication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17628586      PMCID: PMC2039909          DOI: 10.1016/j.jim.2007.05.011

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  36 in total

1.  The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration.

Authors:  Michael R Betts; David A Price; Jason M Brenchley; Karin Loré; F Javier Guenaga; Anna Smed-Sorensen; David R Ambrozak; Stephen A Migueles; Mark Connors; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

2.  Detection of T-cell degranulation: CD107a and b.

Authors:  Michael R Betts; Richard A Koup
Journal:  Methods Cell Biol       Date:  2004       Impact factor: 1.441

3.  Vaccination in humans generates broad T cell cytokine responses.

Authors:  Stephen C De Rosa; Fabien X Lu; Joanne Yu; Stephen P Perfetto; Judith Falloon; Susan Moser; Thomas G Evans; Richard Koup; Christopher J Miller; Mario Roederer
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

Review 4.  Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking.

Authors:  M Fukuda
Journal:  J Biol Chem       Date:  1991-11-15       Impact factor: 5.157

5.  Simultaneous reconstitution of multiple cytomegalovirus-specific CD8+ cell populations with divergent functionality in hematopoietic stem-cell transplant recipients.

Authors:  Simon F Lacey; Joy Martinez; Ghislaine Gallez-Hawkins; Lia Thao; Jeff Longmate; Wahajul Haq; Ricardo Spielberger; Stephen J Forman; John A Zaia; Don J Diamond
Journal:  J Infect Dis       Date:  2005-02-09       Impact factor: 5.226

6.  Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.

Authors:  D Kägi; F Vignaux; B Ledermann; K Bürki; V Depraetere; S Nagata; H Hengartner; P Golstein
Journal:  Science       Date:  1994-07-22       Impact factor: 47.728

7.  Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection.

Authors:  M F Bachmann; M Barner; A Viola; M Kopf
Journal:  Eur J Immunol       Date:  1999-01       Impact factor: 5.532

8.  CD107a as a functional marker for the identification of natural killer cell activity.

Authors:  Galit Alter; Jessica M Malenfant; Marcus Altfeld
Journal:  J Immunol Methods       Date:  2004-11       Impact factor: 2.303

9.  Phenotypic and functional separation of memory and effector human CD8+ T cells.

Authors:  D Hamann; P A Baars; M H Rep; B Hooibrink; S R Kerkhof-Garde; M R Klein; R A van Lier
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

10.  Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes.

Authors:  P J Peters; J Borst; V Oorschot; M Fukuda; O Krähenbühl; J Tschopp; J W Slot; H J Geuze
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  18 in total

Review 1.  Virus-encoded homologs of cellular interleukin-10 and their control of host immune function.

Authors:  Barry Slobedman; Peter A Barry; Juliet V Spencer; Selmir Avdic; Allison Abendroth
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

2.  Belatacept-Resistant Rejection Is Associated With CD28+ Memory CD8 T Cells.

Authors:  D V Mathews; W C Wakwe; S C Kim; M C Lowe; C Breeden; M E Roberts; A B Farris; E A Strobert; J B Jenkins; C P Larsen; M L Ford; R Townsend; A B Adams
Journal:  Am J Transplant       Date:  2017-07-11       Impact factor: 8.086

3.  IFNγ⁻TNFα⁻IL2⁻MIP1α⁻CD107a⁺PRF1⁺ CD8 pp65-Specific T-Cell Response Is Independently Associated With Time to Death in Elderly Humans.

Authors:  Sara Ferrando-Martínez; Ezequiel Ruiz-Mateos; Joseph P Casazza; Rebeca S de Pablo-Bernal; Beatriz Dominguez-Molina; M Ángeles Muñoz-Fernández; Juan Delgado; Rafael de la Rosa; Rafael Solana; Richard A Koup; Manuel Leal
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-09-18       Impact factor: 6.053

4.  Postnatal acquisition of primary rhesus cytomegalovirus infection is associated with prolonged virus shedding and impaired CD4+ T lymphocyte function.

Authors:  Pierre Antoine; Valerie Varner; Angela Carville; Michelle Connole; Arnaud Marchant; Amitinder Kaur
Journal:  J Infect Dis       Date:  2014-04-08       Impact factor: 5.226

5.  Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge.

Authors:  Scott G Hansen; Cassandra Vieville; Nathan Whizin; Lia Coyne-Johnson; Don C Siess; Derek D Drummond; Alfred W Legasse; Michael K Axthelm; Kelli Oswald; Charles M Trubey; Michael Piatak; Jeffrey D Lifson; Jay A Nelson; Michael A Jarvis; Louis J Picker
Journal:  Nat Med       Date:  2009-02-15       Impact factor: 53.440

6.  Coadministration of telomerase genetic vaccine and a novel TLR9 agonist in nonhuman primates.

Authors:  Sridhar Dharmapuri; Daniela Peruzzi; Carmela Mennuni; Francesco Calvaruso; Saverio Giampaoli; Gaetano Barbato; Ekambar R Kandimalla; Sudhir Agrawal; Elisa Scarselli; Giuseppe Mesiti; Gennaro Ciliberto; Nicola La Monica; Luigi Aurisicchio
Journal:  Mol Ther       Date:  2009-07-21       Impact factor: 11.454

7.  A heterologous DNA prime/protein boost immunization strategy for rhesus cytomegalovirus.

Authors:  Kristina Abel; Lisa Strelow; Yujuan Yue; Meghan K Eberhardt; Kimberli A Schmidt; Peter A Barry
Journal:  Vaccine       Date:  2008-08-27       Impact factor: 3.641

8.  Increased loss of CCR5+ CD45RA- CD4+ T cells in CD8+ lymphocyte-depleted Simian immunodeficiency virus-infected rhesus monkeys.

Authors:  Ronald S Veazey; Paula M Acierno; Kimberly J McEvers; Susanne H C Baumeister; Gabriel J Foster; Melisa D Rett; Michael H Newberg; Marcelo J Kuroda; Kenneth Williams; Eun-Young Kim; Steven M Wolinsky; E Peter Rieber; Michael Piatak; Jeffrey D Lifson; David C Montefiori; Charles R Brown; Vanessa M Hirsch; Jörn E Schmitz
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

Review 9.  Rhesus CMV: an emerging animal model for human CMV.

Authors:  Colin Powers; Klaus Früh
Journal:  Med Microbiol Immunol       Date:  2008-01-11       Impact factor: 3.402

Review 10.  Rhesus monkeys for a nonhuman primate model of cytomegalovirus infections.

Authors:  Hannah L Itell; Amitinder Kaur; Jesse D Deere; Peter A Barry; Sallie R Permar
Journal:  Curr Opin Virol       Date:  2017-09-06       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.